Tower Research Capital (TRC)’s Unicycive Therapeutics UNCY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,089
| Closed | -$8.65K | – | 5808 |
|
|
2024
Q4 | $8.65K | Sell |
1,089
-1,189
| -52% | -$9.44K | ﹤0.01% | 3979 |
|
|
2024
Q3 | $9.3K | Buy |
2,278
+429
| +23% | +$1.75K | ﹤0.01% | 3881 |
|
|
2024
Q2 | $9.26K | Buy |
1,849
+1,081
| +141% | +$5.41K | ﹤0.01% | 4272 |
|
|
2024
Q1 | $10.6K | Buy |
768
+92
| +14% | +$1.27K | ﹤0.01% | 3677 |
|
|
2023
Q4 | $5.87K | Buy |
676
+369
| +120% | +$3.2K | ﹤0.01% | 4796 |
|
|
2023
Q3 | $2.64K | Buy |
307
+100
| +48% | +$859 | ﹤0.01% | 5126 |
|
|
2023
Q2 | $2.65K | Sell |
207
-135
| -39% | -$1.73K | ﹤0.01% | 5148 |
|
|
2023
Q1 | $7K | Sell |
342
-158
| -32% | -$3.23K | ﹤0.01% | 4778 |
|
|
2022
Q4 | $3K | Sell |
500
-18
| -3% | -$108 | ﹤0.01% | 5244 |
|
|
2022
Q3 | $3K | Buy |
518
+1
| +0.2% | +$6 | ﹤0.01% | 5433 |
|
|
2022
Q2 | $4K | Buy |
517
+133
| +35% | +$1.03K | ﹤0.01% | 5260 |
|
|
2022
Q1 | $5K | Buy |
+384
| New | +$5K | ﹤0.01% | 5108 |
|